Each tablet contains Faropenem 200 mg.

Faronac Tablets contain Faropenem, a broad-spectrum oral penem antibiotic with potent bactericidal activity against a wide range of aerobic and anaerobic Gram-positive and Gram-negative bacteria. Faropenem exhibits strong affinity for penicillin-binding proteins (PBPs), enabling effective inhibition of bacterial cell wall synthesis. Its broad antibacterial coverage makes it a reliable therapeutic option for managing respiratory tract, urinary tract, skin, soft tissue, and gynecological infections caused by susceptible pathogens.

Faronac Tablets are indicated for the treatment of upper and lower respiratory tract infections, urinary tract infections, skin and skin structure infections, and gynecological infections caused by susceptible bacterial organisms.

Faropenem is a bactericidal penem antibiotic that acts by binding strongly to high-molecular-weight penicillin-binding proteins (PBPs) located within the bacterial cell wall. These proteins are essential for bacterial growth and multiplication. By inhibiting cell wall synthesis, Faropenem disrupts bacterial integrity and leads to bacterial cell death. The drug demonstrates broad-spectrum antibacterial activity against both aerobic and anaerobic Gram-positive and Gram-negative bacteria, making it effective against a wide variety of clinically relevant pathogens.

The recommended dosage is one tablet administered orally three times daily or as directed by the treating physician. The duration of therapy should be determined based on the severity and type of infection as well as the patient's clinical response.

Faronac Tablets are contraindicated in patients with known hypersensitivity to Faropenem, any component of the formulation, or other drugs belonging to the same class. The product is also contraindicated in patients with a history of severe hypersensitivity or anaphylactic reactions to β-lactam antibiotics.